BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 30192023)

  • 21. Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.
    Atrash S; Zhang Q; Papanikolaou X; Stein C; Abdallah AO; Barlogie B
    J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
    Paiva B; Montes MC; García-Sanz R; Ocio EM; Alonso J; de Las Heras N; Escalante F; Cuello R; de Coca AG; Galende J; Hernández J; Sierra M; Martin A; Pardal E; Bárez A; Alonso J; Suarez L; González-López TJ; Perez JJ; Orfao A; Vidríales MB; San Miguel JF
    Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism.
    Jalali S; Shi J; Ahsan N; Wellik L; Serres M; Buko A; Paludo J; Kim H; Tang X; Yang ZZ; Novak A; Kyle R; Ansell S
    Redox Biol; 2021 May; 41():101927. PubMed ID: 33690107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
    Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
    Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia.
    Kyle RA; Therneau TM; Dispenzieri A; Kumar S; Benson JT; Larson DR; Melton LJ; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):184-6. PubMed ID: 23490989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
    Moreno DF; López-Guerra M; Paz S; Oliver-Caldés A; Mena MP; Correa JG; Battram AM; Osuna M; Rivas-Delgado A; Rodríguez-Lobato LG; Cardús O; Tovar N; Cibeira MT; Jiménez-Segura R; Bladé J; Rosiñol L; Colomer D; Fernández de Larrea C
    Br J Haematol; 2023 Jan; 200(2):187-196. PubMed ID: 36210485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential diagnosis of monoclonal gammopathy.
    Gandara DR; Mackenzie MR
    Med Clin North Am; 1988 Sep; 72(5):1155-67. PubMed ID: 3137401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
    Al-Zuhairy A; Schrøder HD; Plesner T; Abildgaard N; Sindrup SH
    J Neurol Sci; 2015 Feb; 349(1-2):60-4. PubMed ID: 25582978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.
    Paludo J; Ansell SM
    F1000Res; 2017; 6():2142. PubMed ID: 29399323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurologic aspects of plasma cell disorders.
    Sobol U; Stiff P
    Handb Clin Neurol; 2014; 120():1083-99. PubMed ID: 24365373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Siakantaris MP; Dimopoulou MN; Vassilakopoulos TP; Tzenou T; Kokoris S; Dimitriadou E; Kalpadakis C; Tsalimalma K; Tsaftaridis P; Panayiotidis P; Angelopoulou MK
    Clin Lymphoma; 2005 Mar; 5(4):235-40. PubMed ID: 15794855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal Gammopathy of Undetermined Significance.
    Gonsalves WI; Rajkumar SV
    Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical practice. Monoclonal gammopathy of undetermined significance.
    Bladé J
    N Engl J Med; 2006 Dec; 355(26):2765-70. PubMed ID: 17192542
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathy and monoclonal gammopathy.
    Nobile-Orazio E
    Handb Clin Neurol; 2013; 115():443-59. PubMed ID: 23931795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.
    Nie G; Sun L; Zhang C; Yuan Y; Mao H; Wang Z; Li J; Duan S; Xing C; Zhang B
    Front Immunol; 2022; 13():903315. PubMed ID: 36172352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
    Greco A; Tedeschi A; Varettoni M; Nichelatti M; Paris L; Ricci F; Vismara E; Morra E
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):77-9. PubMed ID: 21454196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA
    Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
    Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Mattei D; Strola G; Drandi D; Mordini N; Foglietta M; Rapezzi D; Celeghini I; Grasso M; Giordano F; Fraternali Orcioni G; Massaia M
    J Med Case Rep; 2020 Jun; 14(1):75. PubMed ID: 32564775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.